Latest Insider Transactions at Olema Pharmaceuticals, Inc. (OLMA)
This section provides a real-time view of insider transactions for Olema Pharmaceuticals, Inc. (OLMA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Olema Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Olema Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 11
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-46.82%
|
$141,777
$27.83 P/Share
|
|
Oct 11
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+42.72%
|
$10,502
$2.06 P/Share
|
|
Sep 27
2021
|
Sean Bohen PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
1,085
-2.02%
|
$32,550
$30.07 P/Share
|
|
Sep 27
2021
|
Sean Bohen PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,085
+1.98%
|
$4,340
$4.82 P/Share
|
|
Sep 20
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
12,000
-1.12%
|
$312,000
$26.3 P/Share
|
|
Sep 10
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-74.58%
|
$152,279
$29.38 P/Share
|
|
Sep 10
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+42.72%
|
$10,502
$2.06 P/Share
|
|
Sep 08
2021
|
Sean Bohen PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
2,631
-4.77%
|
$78,930
$30.0 P/Share
|
|
Sep 08
2021
|
Sean Bohen PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,631
+4.42%
|
$10,524
$4.82 P/Share
|
|
Sep 07
2021
|
Sean Bohen PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
413
-0.76%
|
$12,390
$30.08 P/Share
|
|
Sep 07
2021
|
Sean Bohen PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
413
+0.75%
|
$1,652
$4.82 P/Share
|
|
Sep 01
2021
|
Sean Bohen PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
871
-1.58%
|
$26,130
$30.05 P/Share
|
|
Sep 01
2021
|
Sean Bohen PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
871
+1.55%
|
$3,484
$4.82 P/Share
|
|
Aug 19
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
12,000
-1.1%
|
$288,000
$24.97 P/Share
|
|
Aug 10
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-38.48%
|
$131,275
$25.94 P/Share
|
|
Aug 10
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+42.72%
|
$10,502
$2.06 P/Share
|
|
Jul 20
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
4,123
-0.38%
|
$103,075
$25.63 P/Share
|
|
Jul 19
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
7,877
-0.72%
|
$189,048
$24.83 P/Share
|
|
Jul 12
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-49.28%
|
$136,526
$26.67 P/Share
|
|
Jul 12
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+42.72%
|
$10,502
$2.06 P/Share
|
|
Jun 18
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
12,000
-0.36%
|
$300,000
$25.48 P/Share
|
|
Jun 10
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-32.42%
|
$152,279
$29.29 P/Share
|
|
Jun 10
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+42.72%
|
$10,502
$2.06 P/Share
|
|
May 18
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
57,763
-82.66%
|
$1,386,312
$24.42 P/Share
|
|
May 18
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,763
+49.24%
|
$115,526
$2.06 P/Share
|
|
Mar 31
2021
|
Bvf Partners L P Director |
BUY
Other acquisition or disposition
|
Indirect |
99,556
+50.0%
|
-
|
|
Nov 23
2020
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,725,406
+35.38%
|
-
|
|
Nov 23
2020
|
Cyrus Harmon |
BUY
Conversion of derivative security
|
Indirect |
122,028
+50.0%
|
-
|
|
Nov 23
2020
|
Cyrus Harmon |
BUY
Conversion of derivative security
|
Direct |
71,374
+6.03%
|
-
|
|
Nov 23
2020
|
Peter J. Kushner CHIEF SCIENTIFIC OFFICER |
BUY
Conversion of derivative security
|
Direct |
358,920
+11.64%
|
-
|
|
Nov 23
2020
|
Frank Mccormick Director |
BUY
Conversion of derivative security
|
Indirect |
66,326
+44.05%
|
-
|
|
Nov 23
2020
|
Frank Mccormick Director |
BUY
Conversion of derivative security
|
Direct |
152,891
+44.44%
|
-
|
|
Nov 23
2020
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
BUY
Conversion of derivative security
|
Indirect |
167,677
+50.0%
|
-
|
|
Nov 23
2020
|
Andrew Rappaport |
BUY
Conversion of derivative security
|
Indirect |
448,556
+34.42%
|
-
|
|
Nov 23
2020
|
G. Walmsley Graham Director |
BUY
Open market or private purchase
|
Indirect |
1,160,000
+50.0%
|
$22,040,000
$19.0 P/Share
|
|
Nov 23
2020
|
G. Walmsley Graham Director |
BUY
Conversion of derivative security
|
Indirect |
2,583,875
+50.0%
|
-
|
|
Nov 23
2020
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
425,000
+11.5%
|
$8,075,000
$19.0 P/Share
|
|
Nov 23
2020
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
2,845,544
+50.0%
|
-
|
|
Nov 19
2020
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
1,135,334
+15.01%
|
$21,571,346
$19.0 P/Share
|
|
Nov 19
2020
|
Bvf Partners L P Director |
BUY
Conversion of derivative security
|
Direct |
5,216,676
+32.82%
|
-
|
|
Sep 23
2020
|
Sean Bohen PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,649
+50.0%
|
$206,596
$4.82 P/Share
|
|
Sep 16
2020
|
Cynthia M Butitta |
BUY
Exercise of conversion of derivative security
|
Direct |
83,876
+50.0%
|
$335,504
$4.41 P/Share
|
|
Jun 15
2020
|
Cyrus Harmon |
BUY
Grant, award, or other acquisition
|
Direct |
143,472
+12.12%
|
-
|
|
Jun 15
2020
|
Shane William Charles Kovacs CH. OPERATING & FINANCIAL OFF. |
BUY
Grant, award, or other acquisition
|
Direct |
358,680
+50.0%
|
-
|
|
Jun 15
2020
|
Peter J. Kushner CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
143,472
+11.8%
|
-
|
|
Jun 15
2020
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
BUY
Grant, award, or other acquisition
|
Direct |
143,472
+19.51%
|
-
|